These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


232 related items for PubMed ID: 15319442

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. A cyclic peptide mimicking the third intracellular loop of the V2 vasopressin receptor inhibits signaling through its interaction with receptor dimer and G protein.
    Granier S, Terrillon S, Pascal R, Déméné H, Bouvier M, Guillon G, Mendre C.
    J Biol Chem; 2004 Dec 03; 279(49):50904-14. PubMed ID: 15452133
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Cellular and subcellular distribution of the type-2 vasopressin receptor in the kidney.
    Fenton RA, Brønd L, Nielsen S, Praetorius J.
    Am J Physiol Renal Physiol; 2007 Sep 03; 293(3):F748-60. PubMed ID: 17553938
    [Abstract] [Full Text] [Related]

  • 32. Characterization of a functional V1B vasopressin receptor in the male rat kidney: evidence for cross talk between V1B and V2 receptor signaling pathways.
    Hus-Citharel A, Bouby N, Corbani M, Mion J, Mendre C, Darusi J, Tomboly C, Trueba M, Serradeil-Le Gal C, Llorens-Cortes C, Guillon G.
    Am J Physiol Renal Physiol; 2021 Sep 01; 321(3):F305-F321. PubMed ID: 34282956
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Regulation of the dual specificity protein phosphatase, DsPTP1, through interactions with calmodulin.
    Yoo JH, Cheong MS, Park CY, Moon BC, Kim MC, Kang YH, Park HC, Choi MS, Lee JH, Jung WY, Yoon HW, Chung WS, Lim CO, Lee SY, Cho MJ.
    J Biol Chem; 2004 Jan 09; 279(2):848-58. PubMed ID: 14570888
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Expression, purification and NMR characterization of the cyclic recombinant form of the third intracellular loop of the vasopressin type 2 receptor.
    Bellot G, Pascal R, Mendre C, Urbach S, Mouillac B, Déméné H.
    Protein Expr Purif; 2011 Aug 09; 78(2):131-8. PubMed ID: 21575724
    [Abstract] [Full Text] [Related]

  • 38. Soluble mimics of the cytoplasmic face of the human V1-vascular vasopressin receptor bind arrestin2 and calmodulin.
    Wu N, Macion-Dazard R, Nithianantham S, Xu Z, Hanson SM, Vishnivetskiy SA, Gurevich VV, Thibonnier M, Shoham M.
    Mol Pharmacol; 2006 Jul 09; 70(1):249-58. PubMed ID: 16574744
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 12.